Education
About Us
Working with TipRanks
Follow Us
Naturhouse Health (ES:NTH)
BME:NTH
NTH Stock Chart & Stats
€2.30
€0.03(1.46%)
At close: 4:00 PM EST
€2.30
€0.03(1.46%)
Day’s Range― - ―
52-Week Range€1.65 - €2.82
Previous CloseN/A
Volume12.72K
Average Volume (3M)24.74K
Market Cap
€151.67M
Enterprise Value€129.01M
Total Cash (Recent Filing)€23.34M
Total Debt (Recent Filing)€2.72M
Price to Earnings (P/E)14.8
Beta0.17
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield11.15%
Share Statistics
EPS (TTM)0.16
Shares Outstanding60,000,000
10 Day Avg. Volume17,416
30 Day Avg. Volume24,740
Financial Highlights & Ratios
PEG Ratio-0.64
Price to Book (P/B)3.14
Price to Sales (P/S)2.01
P/FCF Ratio8.87
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.16
Revenue Forecast (FY)€48.80M
Bulls Say, Bears Say
Bulls Say
High Gross MarginsSustained gross margins above 70% indicate durable product-level profitability and pricing power. This margin buffer supports operating profitability even if top-line growth slows, allowing Naturhouse to fund marketing, retain consultants, and maintain EBITDA margins over the medium term.
Recurring Product + Franchised Network ModelA hybrid model combining dietitian-led services that drive recurring product purchases and franchise fee/royalty streams creates stable, repeatable revenue. This service-to-product funnel and franchising scalability support steady cash generation and geographic expansion over multiple quarters.
Low Leverage And Strong Equity BaseLow leverage and a healthy equity ratio provide financial resilience, lowering refinancing risk and giving management flexibility to invest in centers, R&D, or shareholder returns. Strong ROE noted suggests equity is being used effectively to generate profit sustainably.
Bears Say
Declining Revenue TrendA multi-year revenue decline erodes scale economies and reduces recurring product sales linked to consultations. Persistent top-line contraction can pressure fixed-cost coverage, limit franchise attractiveness, and make sustaining marketing or expansion investments harder over the medium term.
Weakening Free Cash Flow GrowthFalling or negative free cash flow growth constrains the company's ability to reinvest, pay dividends, or fund franchise support without external financing. Even with solid operating cash relative to income, weakening FCF undermines long-term financial flexibility and capacity to scale.
Declining Total AssetsA shrinking asset base may reflect asset sales, reduced investment in centers, or contracting operations. Over time this can limit distribution capacity, inventory buffering, and growth potential, signaling possible erosion of operational scale and future revenue-generating capacity.
Naturhouse Health News
NTH FAQ
What was Naturhouse Health’s price range in the past 12 months?
Naturhouse Health lowest stock price was €1.65 and its highest was €2.82 in the past 12 months.
What is Naturhouse Health’s market cap?
Naturhouse Health’s market cap is €151.67M.
When is Naturhouse Health’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Naturhouse Health’s earnings last quarter?
Naturhouse Health released its earnings results on Feb 26, 2024. The company reported €0.065 earnings per share for the quarter, beating the consensus estimate of N/A by €0.065.
Is Naturhouse Health overvalued?
According to Wall Street analysts Naturhouse Health’s price is currently Overvalued.
Does Naturhouse Health pay dividends?
Naturhouse Health pays a Quarterly dividend of €0.081 which represents an annual dividend yield of 11.15%. See more information on Naturhouse Health dividends here
What is Naturhouse Health’s EPS estimate?
Naturhouse Health’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Naturhouse Health have?
Naturhouse Health has 60,000,000 shares outstanding.
What happened to Naturhouse Health’s price movement after its last earnings report?
Naturhouse Health reported an EPS of €0.065 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 2.459%.
Which hedge fund is a major shareholder of Naturhouse Health?
Currently, no hedge funds are holding shares in ES:NTH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Naturhouse Health
Naturhouse Health (NTH) is a global leader in the health and wellness sector, specializing in nutritional counseling and weight management solutions. The company operates through a franchise model, providing its clients with personalized dietary plans, supplements, and a range of health-related products. NTH focuses on promoting healthy lifestyles through its innovative programs that cater to individual needs, making it a trusted partner in achieving weight loss and overall well-being.
Technical Analysis
LABORATORIO REIG JOFRE
―
DEOLEO S.A.
―
PRIM, S.A.
―
Atrys Health SA
―
Labiana Health SA
―
Options Prices
Currently, No data available
---